Scribd Logo
Upload

Welcome to Scribd!

  • Kelompok 3

    Uploaded by

    Nadia Helena
    3 views2 pages
    - The document discusses the merger between two large pharmaceutical companies, Daiichi Sankyo and Ranbaxy, which was completed in June 2014. - The merger created one of the largest pharmaceutical companies in India and Japan, with a combined portfolio of both companies' generic and branded pharmaceutical products. - The combined company aimed to leverage both companies' strengths in research and development, manufacturing, and distribution networks in order to expand globally and become a top 10 pharmaceutical company worldwide.

    Original Description:

    Original Title

    KELOMPOK 3

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    - The document discusses the merger between two large pharmaceutical companies, Daiichi Sankyo and Ranbaxy, which was completed in June 2014. - The merger created one of the largest pharmaceutical companies in India and Japan, with a combined portfolio of both companies' generic and branded pharmaceutical products. - The combined company aimed to leverage both companies' strengths in research and development, manufacturing, and distribution networks in order to expand globally and become a top 10 pharmaceutical company worldwide.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    3 views2 pages

    Kelompok 3

    Uploaded by

    Nadia Helena
    - The document discusses the merger between two large pharmaceutical companies, Daiichi Sankyo and Ranbaxy, which was completed in June 2014. - The merger created one of the largest pharmaceutical companies in India and Japan, with a combined portfolio of both companies' generic and branded pharmaceutical products. - The combined company aimed to leverage both companies' strengths in research and development, manufacturing, and distribution networks in order to expand globally and become a top 10 pharmaceutical company worldwide.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    •

    ti . . . .
    ~ p~ uc j_,3 _ - - - - - : - - - - - -- - - - - -
    ~ fY\ rvnen rnefAfC( errvm~ct n

    ~ l ~h°'n
    V"- - - : _ll_
    . Wl MeOOc.
    CDJn f\JU/1 2[,{tr 2tU hll 111.~ un_lt{.:__c_ M_e..mh ,w_1a1._M_r
    .:. . .:.:..- {<'_
    ~ --=
    ho:____

    ~ ~etnhC1 ~ btMa.n IYtflc~ l1nJ h,,c 1W ll'l{llt.trn ltngf:,Jy II yq f',/Jutu '

    -------------.----:----
    ()--------Jh @Jvr - fct~M f Mel ,e l)jehthtxro b rn
    ~
    unJth:
    -- - (Af Cl ,, IICl\ro/Jj
    ---=-- ~Uh'1h' ,- ph ('(1eclJt,
    CL-__ - O~ftJffl - Mu
    0--- -- ~bv1h01h - ~nmn~~

    (>_ _c. J\llC(ql'v\- m¥'ctlYI ty\(>oUZf },erzAt;jc-tft" lcet,'-flcuu,fl1/(· .


    (?__ - tnectt~ VJY\llt'1 cm l rrecV C1 eC{ck<l yg ,w,n~tiCW10 ~ hC1h -- IXi_no11
    C! l\(OIY}\rct_"
    ""' flt-e tk l-1 hrin~ pcrzu1 f Cvf\ ( &l'v~ M , CHYlr eJ , <{Xa/\ c{frvfJ· fe/7M
    (?_- ----.:-~ ~~o4
    ~t:1.~ dtP
    ~ ~~4 ~ ~ {_l!:_
    2@~aj~u1~n~r1<--_ 1yq C4t ~~
    ~ c;!{~~~f'>l~h~~ht~ ~ Peti0,
    ~~rA:I_r~
    C?- - -_:~~~:_.::tv\t::_
    c~h~c~~ - - - - - - - -- -- -
    - t},ectJ.Ci\ ltte;tchf olren{eh dc,_yj bah~n b1>11c, PeWo/TIC, qn4hre;hrc

    I. ..,
    daiichi
    ~

    ~
    -;-----=--=•- "-T---;---- ---;- -:----:-- ------,-- -------= ----;------= -- ------:-- -~
    _1..£...t_. ~ ;~en'!. . !.:.~f-M..a(Wu
    l.! .;_~·_Jrve
    ~· cu~e, _ _ _ _ _ _ _ _ _ __ _ _ _ _·~
    -- - - ~~~n:J._____!lm~~~ M~Ji_J,C.~C~,L!{A l\ ~(~ Pv~tY\~h e
    r .~ ~r~run
    ~ Vl~ .~
    nl~h ~~ ~ h_.,_,_ V(~~ ::..:.fn:.:. _:__:n~ - - - ,
    fvl111.r
    1Y'Uvl
    ~~ Cl9JLa4J
    ~ ~- - - - - - - - - -c,-l - ,~
    - - - - - , :,,J__:_:_:
    - _____ __ .
    - Y~l'I ~ - 7 mcu,;
    fX,dvnm trtim}]JJ'J(C,vl Nf,v 3't

    You might also like